Diffusion of the D.A.R.E and Syringe Exchange Programs

Overview

Journal Am J Public Health

Specialty Public Health

Date 2006 Jul 1

PMID 16809601

Citations 19

Authors

Don C Des Jarlais

Zili Sloboda

Samuel R Friedman

Barbara Tempalski

Courtney McKnight

Naomi Braine

Affiliations

Soon will be listed here.

Abstract

We examined the diffusion of the D.A.R.E program to reduce use of illicit drugs among school-aged children and youths and the diffusion of syringe exchange programs to reduce HIV transmission among injection drug users. The D.A.R.E program was diffused widely in the United States despite a lack of evidence for its effectiveness; there has been limited diffusion of syringe exchange in the United States, despite extensive scientific evidence for its effectiveness. Multiple possible associations between diffusion and evidence of effectiveness exist, from widespread diffusion without evidence of effectiveness to limited diffusion with strong evidence of effectiveness. The decision theory concepts of framing and loss aversion may be useful for further research on the diffusion of public health innovations.

Citing Articles

A Framework for Introducing Global Health Innovations to the US.

Shin S, Lapinski M, Hussain S, Rumbold Y, Osoro R, Shell D Ann Glob Health. 2022; 88(1):67.

PMID: 36043039 PMC: 9374027. DOI: 10.5334/aogh.3600.

Perceived difficulty of getting help to reduce or abstain from substances among sexual and gender minority men who have sex with men (SGMSM) and use methamphetamine during the early period of the COVID-19 pandemic.

Card K, McGuire M, Bond-Gorr J, Nguyen T, Wells G, Fulcher K Subst Abuse Treat Prev Policy. 2021; 16(1):88.

PMID: 34903260 PMC: 8667539. DOI: 10.1186/s13011-021-00425-3.

The stigma system: How sociopolitical domination, scapegoating, and stigma shape public health.

Friedman S, Williams L, Guarino H, Mateu-Gelabert P, Krawczyk N, Hamilton L J Community Psychol. 2021; 50(1):385-408.

PMID: 34115390 PMC: 8664901. DOI: 10.1002/jcop.22581.

Predictors of US states' adoption of naloxone access laws, 2001-2017.

Bohler R, Hodgkin D, Kreiner P, Green T Drug Alcohol Depend. 2021; 225:108772.

PMID: 34052687 PMC: 8282714. DOI: 10.1016/j.drugalcdep.2021.108772.

Designing Evidence-Based Preventive Interventions That Reach More People, Faster, and with More Impact in Global Contexts.

Rotheram-Borus M Annu Rev Clin Psychol. 2021; 17:551-575.

PMID: 33962538 PMC: 10015738. DOI: 10.1146/annurev-clinpsy-081219-120453.

References

Des Jarlais D, Friedman S, Ward T . Harm reduction: a public health response to the AIDS epidemic among injecting drug users. Annu Rev Public Health. 1993; 14:413-50. DOI: 10.1146/annurev.pu.14.050193.002213. View

Hagan H, Des Jarlais D, Purchase D, Reid T, Friedman S . The Tacoma Syringe Exchange. J Addict Dis. 1991; 10(4):81-8. DOI: 10.1300/J069v10n04_06. View

Bruneau J, Lamothe F, Franco E, Lachance N, Desy M, Soto J . High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study. Am J Epidemiol. 1998; 146(12):994-1002. DOI: 10.1093/oxfordjournals.aje.a009240. View

Blendon R, Young J . The public and the war on illicit drugs. JAMA. 1998; 279(11):827-32. DOI: 10.1001/jama.279.11.827. View

Gibson D, Flynn N, Perales D . Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS. 2001; 15(11):1329-41. DOI: 10.1097/00002030-200107270-00002. View

Heimer R, Kaplan E, Khoshnood K, Jariwala B, Cadman E . Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut. Am J Med. 1993; 95(2):214-20. DOI: 10.1016/0002-9343(93)90263-o. View

Dunlap E, Johnson B . The setting for the crack era: macro forces, micro consequences (1960-1992). J Psychoactive Drugs. 1992; 24(4):307-21. PMC: 2761228. DOI: 10.1080/02791072.1992.10471656. View

Strathdee S, Patrick D, Currie S, Cornelisse P, Rekart M, Montaner J . Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS. 1997; 11(8):F59-65. DOI: 10.1097/00002030-199708000-00001. View

Hagan H, Jarlais D, Friedman S, Purchase D, Alter M . Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. Am J Public Health. 1995; 85(11):1531-7. PMC: 1615682. DOI: 10.2105/ajph.85.11.1531. View

10.

Stimson G . Syringe-exchange programmes for injecting drug users. AIDS. 1989; 3(5):253-60. DOI: 10.1097/00002030-198905000-00001. View

11.

Kaldor J, Elford J, Wodak A, Crofts J, Kidd S . HIV prevalence among IDUs in Australia: a methodological review. Drug Alcohol Rev. 1993; 12(2):175-84. DOI: 10.1080/09595239300185611. View

12.

Hallfors D, Godette D . Will the 'principles of effectiveness' improve prevention practice? Early findings from a diffusion study. Health Educ Res. 2002; 17(4):461-70. DOI: 10.1093/her/17.4.461. View

13.

Paone D, Clark J, Shi Q, Purchase D, Des Jarlais D . Syringe exchange in the United States, 1996: a national profile. Am J Public Health. 1999; 89(1):43-6. PMC: 1508486. DOI: 10.2105/ajph.89.1.43. View

14.

van Ameijden E, van den Hoek J, Van Haastrecht H, Coutinho R . The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injecting drug users, Amsterdam. Am J Epidemiol. 1992; 136(2):236-43. DOI: 10.1093/oxfordjournals.aje.a116489. View

15.

Stimson G . AIDS and injecting drug use in the United Kingdom, 1987-1993: the policy response and the prevention of the epidemic. Soc Sci Med. 1995; 41(5):699-716. DOI: 10.1016/0277-9536(94)00435-v. View

16.

Des Jarlais D, Hagan H, Friedman S, Friedmann P, Goldberg D, Frischer M . Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA. 1995; 274(15):1226-31. DOI: 10.1001/jama.274.15.1226. View

17.

Ennett S, Tobler N, Ringwalt C, Flewelling R . How effective is drug abuse resistance education? A meta-analysis of Project DARE outcome evaluations. Am J Public Health. 1994; 84(9):1394-401. PMC: 1615171. DOI: 10.2105/ajph.84.9.1394. View

18.

MacDonald M, Wodak A, Ali R, Crofts N, Cunningham P, Dolan K . HIV prevalence and risk behaviour in needle exchange attenders: a national study. The Collaboration of Australian Needle Exchanges. Med J Aust. 1997; 166(5):237-40. View